GBUK has acquired Severn Healthcare

Arrowpoint Advisory’s Healthcare team has advised the shareholders of GBUK, a portfolio company of A&M Capital Europe ("AMCE"), on its acquisition of UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.

Headquartered in the United Kingdom, GBUK designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services.

Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, we believe Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.

The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.

Karen Dawaf, Managing Director at Arrowpoint Advisory, commented: “With A&M's backing, GBUK is successfully pursuing a buy and build strategy in the medtech distribution market. It was a pleasure to support the team in their most recent acquisition of Severn Healthcare, a specialist distributor of single-use medical devices.”

Contact the deal team

Discover our Buy-side TRANSACTIONS